Table 1.
Baseline Characteristics.
| Baseline Characteristics | COVID-19 (n = 37) |
Non-COVID-19 (n = 505) |
p-Value |
|---|---|---|---|
| Age | 61.0 (47.5–72.0) | 69.5 (58.5–79.0) | 0.002 |
| Female | 11 (29.7%) | 186 (36.8%) | 0.386 |
| Comorbidities | |||
| Heart rhythm disturbances | 8 (21.6%) | 141 (27.9%) | 0.407 |
| Coronary heart disease | 9 (24.3%) | 130 (25.7%) | 0.849 |
| Obesity | 7 (18.9%) | 60 (11.9%) | 0.200 |
| Pulmonary disease | 6 (16.2%) | 101 (20.0%) | 0.577 |
| Liver disease | 1 (2.7%) | 46 (9.1%) | 0.237 |
| Chronic kidney disease | 7 (18.9%) | 104 (20.6%) | 0.807 |
| Peripheral/cerebral arterial occlusive disease | 2 (5.4%) | 59 (11.7%) | 0.415 |
| Neurologic disease | 4 (10.8%) | 122 (24.2%) | 0.064 |
| Malignancy | 5 (13.5%) | 83 (16.4%) | 0.642 |
| Psychiatric disease | 2 (5.4%) | 56 (11.1%) | 0.410 |
| Dementia | 0 (0.0%) | 28 (5.5%) | 0.246 |
| Alcohol abuse | 0 (0.0%) | 45 (8.9%) | 0.062 |
| Drug abuse | 0 (0.0%) | 18 (3.6%) | 0.626 |
Data given as absolute numbers n (% of all patients) or median and interquartile range (25th–75th). p-value reported in bold if difference is significant (p < 0.05).